Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NGM Biopharmaceuticals names new president and CFO

This article was originally published in Scrip

Executive Summary

San Francisco–based, privately held NGM Biopharmaceuticals has appointed Jeff Jonker president, and Dr David Woodhouse chief financial officer, both effective immediately. The appointments are aimed at expanding the company in line with its collaboration with Merck & Co. Mr Jonker was previously senior vice-president of corporate and business development at Theravance, and has also held leadership positions at Genentech and Satori Pharmaceuticals. Dr Woodhouse joins NGM from Goldman Sachs where he was managing director and co-head of US biotechnology investment banking.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts